Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico
· Delayed Price · Currency is MXN 84.00
0.00 (0.00%)
At close: May 7, 2025
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $14.75M USD in the quarter ending March 31, 2025, with 6.89% growth. This brings the company's revenue in the last twelve months to $59.79M, up 29.32% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm)
$59.79M
Revenue Growth
+29.32%
P/S Ratio
30.34
Revenue / Employee
$74.74K
Employees
800
Market Cap
37.08B MXN
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 972.31B |
| Grupo Financiero Banorte | 131.20B |
| Arca Continental | 245.87B |
| GMéxico Transportes | 61.50B |
| FIBRA Prologis | 11.79B |
| Fibra UNO | 29.47B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 18.37B |
| Becle | 44.63B |